Retrovirus-induced spongiform neurodegeneration is mediated by unique central nervous system viral targeting and expression of env alone

Journal of Virology

Volumn 85, Issue 5, 2011, Pages 2060-2078

  Li, Ying ^a,b,c   Cardona, Sandra M ^a,b   Traister, Russell S ^a,d   Lynch, William P ^a,b  

^a Northeastern Ohio Medical University   (United States)

^b KENT STATE UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; POL PROTEIN; PROTEIN CASBRE; PROTEIN CASE; PROTEIN CASES; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SPONGIOSIS; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EXPRESSION VECTOR; FRIEND LEUKEMIA VIRUS; MOUSE; MURINE LEUKEMIA VIRUS; NERVE DEGENERATION; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; TARGET CELL; VIRUS ENTRY; VIRUS VIRULENCE;

ANIMALS; CELL LINE; FRIEND MURINE LEUKEMIA VIRUS; HUMANS; LEUKEMIA VIRUS, MURINE; MICE; NERVE DEGENERATION; NEURAL STEM CELLS; NEURODEGENERATIVE DISEASES; RETROVIRIDAE INFECTIONS; VIRAL ENVELOPE PROTEINS; VIRULENCE;

MURINE LEUKEMIA VIRUS;

EID: 79551718948     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02210-10     Document Type: Article

References (65)

1. Andrews, J. M., and M. B. Gardner. 1974. Lower motor neuron degeneration associated with type C RNA virus infection in mice: neuropathological features. J. Neuropathol. Exp. Neurol. 33:285-307.
2. Askovic, S., F. J. McAtee, C. Favara, and J. L. Portis. 2000. Brain infection by neuroinvasive but avirulent murine oncornaviruses. J. Virol. 74:465-473.
3. Baszler, T. V., and J. F. Zachary. 1991. Murine retroviral neurovirulence correlates with an enhanced ability of virus to infect selectively, replicate in, and activate resident microglial cells. Am. J. Pathol. 138:655-671. (Erratum, 138:1058.)
4. Baszler, T. V., and J. F. Zachary. 1990. Murine retroviral-induced spongiform neuronal degeneration parallels resident microglial cell infection: ultrastructural findings. Lab. Invest. 63:612-623.
5. Battini, J. L., J. E. Rasko, and A. D. Miller. 1999. A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction. Proc. Natl. Acad. Sci. U. S. A. 96:1385-1390.
6. Brooks, B. R., J. R. Swarz, O. Narayan, and R. T. Johnson. 1979. Murine neurotropic retrovirus spongiform polioencephalomyelopathy: acceleration of disease by virus inoculum concentration. Infect. Immun. 23:540-544.
7. Buller, R. S., K. Wehrly, J. L. Portis, and B. Chesebro. 1990. Host genes conferring resistance to a central nervous system disease induced by a polytropic recombinant Friend murine retrovirus. J. Virol. 64:493-498. (Pubitemid 20032658)
8. Chesebro, B., et al. 1983. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus. Virology 127:134-148. (Pubitemid 13058255)
9. Chesebro, B., et al. 2005. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308:1435-1439. (Pubitemid 40791292)
10. Clase, A. C., et al. 2006. Oligodendrocytes are a major target of the toxicity of spongiogenic murine retroviruses. Am. J. Pathol. 169:1026-1038.
11. Czub, M., S. Czub, F. McAtee, and J. Portis. 1991. Age-dependent resistance to murine retrovirus-induced spongiform neurodegeneration results from CNS-specific restriction of virus replication. J. Virol. 65:2539-2544.
12. Czub, M., F. J. McAtee, and J. L. Portis. 1992. Murine retrovirus-induced spongiform encephalomyelopathy: host and viral factors which determine the length of the incubation period. J. Virol. 66:3298-3305.
13. Czub, S., W. P. Lynch, M. Czub, and J. L. Portis. 1994. Kinetic analysis of the spongiform neurodegenerative disease induced by a highly virulent murine retrovirus. Lab. Invest. 70:711-723.
14. DesGroseillers, L., M. Barrette, and P. Jolicoeur. 1984. Physical mapping of the paralysis-inducing determinant of a wild mouse ecotropic neurotropic virus. J. Virol. 52:356-363. (Pubitemid 15202469)
15. Dimcheff, D. E., L. G. Volkert, Y. Li, A. L. DeLucia, and W. P. Lynch. 2006. Gene expression profiling of microglia infected by a highly neurovirulent murine leukemia virus: implications for neuropathogenesis. Retrovirology 3:26.
16. Evans, L. H., R. P. Morrison, F. G. Malik, J. Portis, and W. J. Britt. 1990. A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J. Virol. 64:6176-6183.
17. Gardner, M. B. 1985. Retroviral spongiform polioencephalomyelopathy. Rev. Infect. Dis. 7:99-110.
18. Gardner, M. B., et al. 1973. A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. J. Natl. Cancer Inst. 51:1243-1254.
19. Gardner, M. B., et al. 1976. Lower motor neuron disease in wild mice caused by indigenous type C virus and search for a similar etiology in human amyotrophic lateral sclerosis. UCLA Forum Med. Sci. 19:217-234.
20. Gravel, C., D. G. Kay, and P. Jolicoeur. 1993. Identification of the infected target cell type in spongiform myeloencephalopathy induced by the neurotropic Cas-Br-E murine leukemia virus. J. Virol. 67:6648-6658. (Pubitemid 23309132)
21. Hansen, R., et al. 2000. Abundant defective viral particles budding from microglia in the course of retroviral spongiform encephalopathy. J. Virol. 74:1775-1780. (Pubitemid 30434035)
22. Hansen, R., et al. 2001. Activation of microglia cells is dispensable for the induction of rat retroviral spongiform encephalopathy. J. Neurovirol. 7:501-510. (Pubitemid 34041051)
23. Jolicoeur, P., C. Gravel, and D. G. Kay. 1992. Pathogenesis of murine spongiform myeloencephalopathy induced by a murine retrovirus, p. 199-224. In R. P. Roos (ed.), Molecular neurovirology. Humana Press, Inc., Totowa, NJ.
24. Kavanaugh, M., et al. 1994. Cell surface receptor for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. U. S. A. 91:7071-7075.
25. Kay, D. G., et al. 1993. Neurological disease induced in transgenic mice expressing the env gene of the Cas-Br-E murine retrovirus. Proc. Natl. Acad. Sci. U. S. A. 90:4538-4542.
26. Kay, D. G., C. Gravel, Y. Robitaille, and P. Jolicoeur. 1991. Retrovirus-induced spongiform myeloencephalopathy in mice: regional distribution of infected target cells and neuronal loss occurring in the absence of viral expression in neurons. Proc. Natl. Acad. Sci. U. S. A. 88:1281-1285.
27. Kozak, S. L., and D. Kabat. 1990. Ping-pong amplification of a retroviral vector achieves high level gene expression: human growth hormone production. J. Virol. 64:3500-3508. (Pubitemid 20219556)
28. Li, Y., and W. P. Lynch. 2010. Misfolding of CasBrE SU is reversed by interactions with 4070A Env: implications for gammaretroviral neuropathogenesis. Retrovirology 7:93.
29. Lynch, W. P., W. J. Brown, G. J. Spangrude, and J. L. Portis. 1994. Microglial infection by a neurovirulent murine retrovirus results in defective processing of envelope protein and intracellular budding of virus particles. J. Virol. 68:3401-3409.
30. Lynch, W. P., S. Czub, F. J. McAtee, S. F. Hayes, and J. L. Portis. 1991. Murine retrovirus-induced spongiform encephalopathy: productive infection of microglia and cerebellar neurons in accelerated CNS disease. Neuron 7:365-379.
31. Lynch, W. P., and J. L. Portis. 2000. Neural stem cells as tools for understanding retroviral neuropathogenesis. Virology 271:227-233.
32. Lynch, W. P., S. J. Robertson, and J. L. Portis. 1995. Induction of focal spongiform neurodegeneration in developmentally resistant mice by implantation of murine retrovirus-infected microglia. J. Virol. 69:1408-1419.
33. Lynch, W. P., A. H. Sharpe, and E. Y. Snyder. 1999. Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration. J. Virol. 73:6841-6851.
34. Lynch, W. P., E. Y. Snyder, L. Qualtiere, J. L. Portis, and A. H. Sharpe. 1996. Late virus replication events in microglia are required for neurovirulent retrovirus-induced spongiform neurodegeneration: evidence from neural progenitor-derived chimeric mouse brains. J. Virol. 70:8896-8907.
35. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62:1120-1124. (Pubitemid 18082924)
36. McAtee, F. J., and J. L. Portis. 1985. Monoclonal antibodies specific for wild mouse neurotropic retrovirus: detection of comparable levels of virus replication in mouse strains susceptible and resistant to paralytic disease. J. Virol. 56:1010-1022.
37. Miller, A. D., M.-F. Law, and I. M. Verma. 1985. Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol. Cell. Biol. 5:431-437.
38. Morey, M. K., and C. A. Wiley. 1990. Immunohistochemical localization of the neurotropic ecotropic murine leukemia virus in moribund mice. Virology 178:104-112. (Pubitemid 20276672)
39. Munk, C., et al. 1997. Amphotropic murine leukemia viruses induce spongiform encephalomyelopathy. Proc. Natl. Acad. Sci. U. S. A. 94:5837-5842.
40. Murphy, S. L., M. J. Honczarenko, N. V. Dugger, P. M. Hoffman, and G. N. Gaulton. 2004. Disparate regions of envelope protein regulate syncytium formation versus spongiform encephalopathy in neurological disease induced by murine leukemia virus TR. J. Virol. 78:8392-8399.
41. Nagra, R. M., P. G. Burrola, and C. A. Wiley. 1992. Development of spongiform encephalopathy in retroviral infected mice. Lab. Invest. 66:292-302.
42. Nishiyama, A., M. Komitova, R. Suzuki, and X. Zhu. 2009. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat. Rev. Neurosci. 10:9-22.
43. O'Doherty, U., W. J. Swiggard, and M. H. Malim. 2000. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 74:10074-10080.
44. Oldstone, M. B. A., F. Jensen, F. J. Dixon, and P. W. Lampert. 1980. Pathogenesis of the slow disease of the central nervous system associated with the wild mouse virus. II. Role of virus and host gene products. Virology 107:180-193.
45. Oldstone, M. B. A., P. W. Lampert, S. Lee, and F. J. Dixon. 1977. Pathogenesis of the slow disease of the central nervous system associated with WM 1504 E virus. I. Relationship of strain susceptibility and replication to disease. Am. J. Pathol. 88:193-212.
46. Portis, J. L. 2001. Genetic determinants of neurovirulence of murine oncornaviruses. Adv. Virus Res. 56:3-38.
47. Portis, J. L., P. Askovich, J. Austin, Y. Gutierrez-Cotto, and F. J. McAtee. 2009. The degree of folding instability of the envelope protein of a neurovirulent murine retrovirus correlates with the severity of the neurological disease. J. Virol. 83:6079-6086.
48. Portis, J. L., S. Czub, C. F. Garon, and F. J. McAtee. 1990. Neurodegenerative disease induced by the Wild Mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus. J. Virol. 64:1648-1656.
49. Portis, J. L., S. Czub, S. Robertson, F. McAtee, and B. Chesebro. 1995. Characterization of a neurologic disease induced by a polytropic murine retrovirus: evidence for differential targeting of ecotropic and polytropic viruses in the brain. J. Virol. 69:8070-8075.
50. Portis, J. L., and W. P. Lynch. 1998. Dissecting the determinants of neuropathogenesis of the murine oncornaviruses. Virology 247:127-136.
51. Robertson, M. N., et al. 1991. Production of monoclonal antibodies reactive with a denatured form of Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and Western blotting. J. Virol. Methods 34:255-271.
52. Robertson, S. J., K. J. Hasenkrug, B. Chesebro, and J. L. Portis. 1997. Neurologic disease induced by polytropic murine retroviruses: neurovirulence determined by efficiency of spread to microglial cells. J. Virol. 71:5287-5294.
53. Ryder, E. F., E. Y. Snyder, and C. L. Cepko. 1990. Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. J. Neurobiol. 21:356-375.
54. Sharpe, A. H., J. J. Hunter, P. Chassler, and R. Jaenisch. 1990. Role of abortive retroviral infection of neurons in spongiform CNS degeneration. Nature 346:181-183.
55. Sherer, N. M., et al. 2007. Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat. Cell Biol. 9:310-315.
56. Sherer, N. M., and W. Mothes. 2008. Cytonemes and tunneling nanotubules in cell-cell communication and viral pathogenesis. Trends Cell Biol. 18:414-420.
57. Snyder, E. Y., et al. 1992. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68:33-51.
58. Szurek, P. F., and B. R. Brooks. 1995. Development of physical forms of unintegrated retroviral DNA in mouse spinal cord tissue during ts1-induced spongiform encephalomyelopathy: elevated levels of a novel single-stranded form in paralyzed mice. J. Virol. 69:348-356.
59. Szurek, P. F., and B. R. Brooks. 1996. ts1-Induced spongiform encephalomyelopathy: physical forms of high-mobility DNA in spinal cord tissues of paralyzed mice are products of premature termination of reverse transcription. J. Virol. 70:2230-2236.
60. Tailor, C. S., A. Nouri, C. G. Lee, C. Kozak, and D. Kabat. 1999. Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc. Natl. Acad. Sci. U. S. A. 96:927-932.
61. Traister, R. S., and W. P. Lynch. 2002. Re-examination of amphotropic murine leukemia virus neurovirulence: NSC-mediated microglial infection fails to induce acute neurodegeneration. Virology 293:262-272.
62. Wong, P. K. Y., and P. H. Yuen. 1992. Molecular basis of neurologic disorders induced by a mutant ts1 of Moloney murine leukemia virus, p. 161-197. In R. Roos (ed.), Molecular neurovirology: pathogenesis of viral CNS infections. Humana Press, Inc., Totowa, NJ.
63. Yang, Y. L., et al. 1999. Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nat. Genet. 21:216-219.
64. Yu, S. S., et al. 2008. Transient gene expression mediated by integrase-defective retroviral vectors. Biochem. Biophys. Res. Commun. 368:942-947.
65. Yu, Y. E., W. Choe, W. Zhang, G. Stoica, and P. K. Wong. 1997. Development of pathological lesions in the central nervous system of transgenic mice expressing the env gene of ts1 Moloney murine leukemia virus in the absence of viral gag and pol genes and viral replication. J. Neurovirol. 3:274-282.